| Lindsey J Soltvedt, PT | |
|
14100 Carlson Pkwy Ste 200, Plymouth, MN 55441-5312 | |
| (763) 519-7900 | |
| (763) 450-0202 |
| Full Name | Lindsey J Soltvedt |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 15 Years |
| Location | 14100 Carlson Pkwy Ste 200, Plymouth, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083845283 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 8327 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Therapy Partners Inc | 4486552593 | 118 |
News Archive
The control and perfectionism that set Olympic athletes apart from their peers at lower levels of competition often have a darker side, according to Kimberly Dennis, M.D., a leading psychiatrist specializing in eating disorder treatment.
Helen M. Genova, PhD, of Kessler Foundation, was awarded a two-year K18 grant for $266,988 from the NIH's National Institute of Mental Health - the NIMH Career Enhancement Award to Advance Autism Services Research for Adults and Transition-Age Youth.
AbbVie, a global biopharmaceutical company, today announced data from the SURVEYOR studies of its investigational HCV regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, that show high rates of sustained virologic response at 12 weeks post-treatment (SVR 12) in non-cirrhotic patients with chronic hepatitis C virus (HCV) infection.
BioDefense Therapeutics—a Joint Product Management office within the U.S. Department of Defense—announced the first patient enrolled in the North American Phase 3 clinical trials for favipiravir (T-705a). The drug is an investigational flu treatment candidate with broad-spectrum potential being developed by BD Tx through a contract with Boston-based MediVector, Inc.
A new study is giving hope to older men who are concerned about the effects of cholesterol-lowering medications on their sexual health.
› Verified 2 days ago
| Provider Name | Fairview Health Services |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
The control and perfectionism that set Olympic athletes apart from their peers at lower levels of competition often have a darker side, according to Kimberly Dennis, M.D., a leading psychiatrist specializing in eating disorder treatment.
Helen M. Genova, PhD, of Kessler Foundation, was awarded a two-year K18 grant for $266,988 from the NIH's National Institute of Mental Health - the NIMH Career Enhancement Award to Advance Autism Services Research for Adults and Transition-Age Youth.
AbbVie, a global biopharmaceutical company, today announced data from the SURVEYOR studies of its investigational HCV regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, that show high rates of sustained virologic response at 12 weeks post-treatment (SVR 12) in non-cirrhotic patients with chronic hepatitis C virus (HCV) infection.
BioDefense Therapeutics—a Joint Product Management office within the U.S. Department of Defense—announced the first patient enrolled in the North American Phase 3 clinical trials for favipiravir (T-705a). The drug is an investigational flu treatment candidate with broad-spectrum potential being developed by BD Tx through a contract with Boston-based MediVector, Inc.
A new study is giving hope to older men who are concerned about the effects of cholesterol-lowering medications on their sexual health.
› Verified 2 days ago
| Provider Name | Therapy Partners Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1407809494 PECOS PAC ID: 4486552593 Enrollment ID: O20031229000333 |
News Archive
The control and perfectionism that set Olympic athletes apart from their peers at lower levels of competition often have a darker side, according to Kimberly Dennis, M.D., a leading psychiatrist specializing in eating disorder treatment.
Helen M. Genova, PhD, of Kessler Foundation, was awarded a two-year K18 grant for $266,988 from the NIH's National Institute of Mental Health - the NIMH Career Enhancement Award to Advance Autism Services Research for Adults and Transition-Age Youth.
AbbVie, a global biopharmaceutical company, today announced data from the SURVEYOR studies of its investigational HCV regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, that show high rates of sustained virologic response at 12 weeks post-treatment (SVR 12) in non-cirrhotic patients with chronic hepatitis C virus (HCV) infection.
BioDefense Therapeutics—a Joint Product Management office within the U.S. Department of Defense—announced the first patient enrolled in the North American Phase 3 clinical trials for favipiravir (T-705a). The drug is an investigational flu treatment candidate with broad-spectrum potential being developed by BD Tx through a contract with Boston-based MediVector, Inc.
A new study is giving hope to older men who are concerned about the effects of cholesterol-lowering medications on their sexual health.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsey J Soltvedt, PT 7581 9th St N Ste 100, Oakdale, MN 55128-6635 Ph: (651) 748-4338 | Lindsey J Soltvedt, PT 14100 Carlson Pkwy Ste 200, Plymouth, MN 55441-5312 Ph: (763) 519-7900 |
News Archive
The control and perfectionism that set Olympic athletes apart from their peers at lower levels of competition often have a darker side, according to Kimberly Dennis, M.D., a leading psychiatrist specializing in eating disorder treatment.
Helen M. Genova, PhD, of Kessler Foundation, was awarded a two-year K18 grant for $266,988 from the NIH's National Institute of Mental Health - the NIMH Career Enhancement Award to Advance Autism Services Research for Adults and Transition-Age Youth.
AbbVie, a global biopharmaceutical company, today announced data from the SURVEYOR studies of its investigational HCV regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, that show high rates of sustained virologic response at 12 weeks post-treatment (SVR 12) in non-cirrhotic patients with chronic hepatitis C virus (HCV) infection.
BioDefense Therapeutics—a Joint Product Management office within the U.S. Department of Defense—announced the first patient enrolled in the North American Phase 3 clinical trials for favipiravir (T-705a). The drug is an investigational flu treatment candidate with broad-spectrum potential being developed by BD Tx through a contract with Boston-based MediVector, Inc.
A new study is giving hope to older men who are concerned about the effects of cholesterol-lowering medications on their sexual health.
› Verified 2 days ago
Paul Julius Solie, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 14100 Carlson Pkwy Ste 200, Plymouth, MN 55441 Phone: 763-519-7900 Fax: 763-450-0202 | |
Alda L Lisk, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5385 Orchid Ln N, Plymouth, MN 55446 Phone: 612-860-1954 | |
Ibackcheck Sports Rehab Physical Therapist Medicare: Medicare Enrolled Practice Location: 2530 Xenium Ln N, Suite 200, Plymouth, MN 55441 Phone: 763-634-8500 | |
Megan Smith-cannistraci, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3025 Harbor Ln N, Suite 314, Plymouth, MN 55447 Phone: 763-559-0356 Fax: 763-559-5193 | |
Sarah Mugge, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4155 County Road 101 N, 2nd Floor, Plymouth, MN 55446 Phone: 952-993-8999 Fax: 952-993-8242 | |
Ms. Katie Jean Ohm, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3401 E Medicine Lake Blvd, Plymouth, MN 55441 Phone: 763-559-3123 |